Business context and reporting period
Onto Innovation designs and supplies semiconductor process-control equipment and software, including metrology, defect inspection and advanced-packaging lithography systems, plus related parts and services. The company reports one operating segment.
Period clarification: Although the request metadata says “2019 Q4,” this is a Form 10-K for the fiscal year ended January 1, 2022 (fiscal 2021, a 53-week year), filed February 25, 2022. The principal comparison is fiscal 2020, ended December 26, 2020.
Financial performance
| Metric | Fiscal 2021 | Fiscal 2020 |
|---|---|---|
| Revenue | $788.9 million | $556.5 million |
| Gross profit / margin | $429.1 million / 54.4% | $278.5 million / 50.0% |
| Operating income / margin | $156.4 million / 19.8% | $26.7 million / 4.8% |
| Net income | $142.3 million | $31.0 million |
| Diluted EPS | $2.86 | $0.63 |
| Cash from operations | $175.3 million | $106.0 million |
Revenue grew 41.8%, driven by demand from foundry and memory customers, advanced-node and specialty-device applications, and advanced packaging. Systems and software generated $669.1 million (85% of revenue); parts $72.8 million (9%); services $47.0 million (6%). Fiscal 2021 included $22.3 million of Inspectrology revenue.
Cash, cash equivalents and marketable securities totaled $511.3 million at year-end, versus $373.7 million a year earlier; working capital was $793.6 million versus $611.6 million. Investing activities used $141.8 million, including $106.0 million net purchases of marketable securities, $23.8 million for Inspectrology and $12.0 million in capital expenditures. Financing activities provided $2.7 million. The filing reports no borrowings; an unused securities-backed credit line provided approximately $131.4 million of availability at a stated 1.8% rate. No cash dividend has been paid, and the $100 million repurchase authorization remained unused at year-end.
Changes and notable items
- Gross margin improved by 4.4 percentage points, reflecting higher factory utilization and the prior-year impact of merger-related inventory fair-value step-up charges and discontinued-product inventory reserves; higher freight and supply-chain costs partly offset the improvement.
- Net income and operating income rose substantially as revenue grew faster than operating expenses. Operating expenses increased to $272.7 million from $251.8 million, including higher headcount and variable compensation; amortization was $51.4 million.
- Inspectrology was acquired in the first quarter for $24.0 million cash, plus contingent consideration. A $2.3 million earnout had been achieved by year-end, with up to $5.0 million of additional potential payment tied to fiscal 2022 results.
- Comparisons with 2019 are affected by the October 2019 merger and reverse-acquisition accounting: Rudolph’s historical operating results are presented before the merger, so 2019 is not a straightforward like-for-like baseline.
Outlook, risks and contingencies
Management described customer demand as strong and said quarterly revenue increased sequentially through 2021 as advanced-node transitions and advanced-packaging volumes grew. It expected semiconductor demand to support longer-term growth, but provided no formal numerical revenue or earnings guidance in the supplied text. Management expected supply-chain uncertainty to remain a factor through at least the first half of 2022 and possibly throughout the year, while stating that available liquidity should cover anticipated needs for the next 12 months.
- Supply chain and costs: Electronic-component shortages, supplier concentration, long lead times, logistics constraints and inflationary costs could delay shipments, reduce margins or result in lost sales. Inventory rose to $243.1 million from $191.2 million; the auditor identified the excess-inventory reserve as a critical audit matter.
- Customer, industry and geographic concentration: TSMC represented 18% of fiscal 2021 revenue and Samsung Semiconductor 16%. Taiwan, South Korea and China together represented 64% of revenue. Semiconductor capital spending is cyclical, and export controls, trade tensions or regional instability could affect demand and sales.
- COVID-19: The company reported no material adverse operational impact to date, but warned that future disruption could affect suppliers, employees, customer qualification, deliveries and demand.
- Other exposures: Product-development and acceptance risk, competition, cybersecurity and intellectual-property disputes, foreign-exchange movements, tax changes and acquisition integration are among the disclosed risks. The company noted that required amortization of U.S. research and development costs beginning in 2022 could reduce cash flow if not deferred or changed.
- Legal matter: The OSI dispute remained in discovery, with trial scheduled for December 2023. Management characterized the loss contingency as remote and did not expect a material effect. Open purchase obligations totaled $373.6 million, including $345.3 million due in less than one year.
Ernst & Young issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded disclosure controls were effective.
Key facts investors should verify
- Confirm the intended period: this filing reports fiscal 2021, not 2019 Q4.
- Assess whether growth and margins are sustainable as component availability, logistics costs and the elevated inventory balance evolve.
- Track revenue concentration, particularly TSMC and Samsung, and exposure to Taiwan, South Korea and China.
- Review the Inspectrology earnout, acquisition integration and any additional fiscal 2022 payment.
- Monitor the $373.6 million purchase-obligation commitment, inventory reserve assumptions, and any changes in the OSI litigation or tax exposures.
- Verify subsequent results against management’s supply-chain outlook and the stated 12-month liquidity assessment.